Nomic is a proteomics company focused on making protein profiling accessible, adaptable, and affordable. The company has developed the nELISA platform, a next-generation immunoassay technology that enables true multiplexing at scale using DNA as a programmable linker.
The Nomic platform offers high-fidelity, flexible, and absolute quantification of proteins, enabling researchers to profile hundreds to thousands of proteins in a single assay with high sensitivity and specificity. Their solutions include Omni 1000, Core, Flex, and end-to-end services designed to support drug discovery, translational research, and in vitro applications.
Backed by automation and expert support, Nomic delivers rapid turnaround times and intuitive analysis tools to transform high-dimensional proteomics data into actionable insights. The company serves institutions worldwide with a mission to democratize proteomics for broader scientific impact.